[Echocardiographic study of patients with hypertrophic obstructive cardiomyopathy during therapy with beta blockers].

M Gebauerová(Institute of Clinical and Experimental Medicine), J Widimský(Institute for Postgraduate Medical Education), P Niederle, J Fabián, P Jebavý, P Krykorka

PubMed

January 1, 1984

Cited by 0

Related Papers

Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

|The Lancet|2022|236

Biochemical Screening for Nonadherence Is Associated With Blood Pressure Reduction and Improvement in Adherence

|Hypertension|2017|194

Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statement

|Nature Reviews Endocrinology|2023|95

A FTO variant and risk of acute coronary syndrome

|Clinica Chimica Acta|2010|65

Does angiotensin-converting enzyme polymorphism influence the clinical manifestation and progression of heart failure in patients with dilated cardiomyopathy?

|The American Journal of Cardiology|1999|32